Advanced

β-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study.

Andell, Pontus LU ; Erlinge, David LU ; Smith, Gustav LU ; Sundström, Johan; Lindahl, Bertil; James, Stefan and Koul, Sasha LU (2015) In Journal of the American Heart Association 4(4). p.001611-001611
Abstract
Patients with myocardial infarction (MI) and concomitant chronic obstructive pulmonary disease (COPD) constitute a high-risk group with increased mortality. β-Blocker therapy has been shown to reduce mortality, prevent arrhythmias, and delay heart failure development after an MI in broad populations. However, the effect of β-blockers in COPD patients is less well established and they may also be less treated due to fear of adverse reactions. We investigated β-blocker prescription at discharge in patients with COPD after MI.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of the American Heart Association
volume
4
issue
4
pages
001611 - 001611
publisher
Wiley-Blackwell
external identifiers
  • pmid:25854796
  • wos:000354137300015
  • scopus:85012249441
ISSN
2047-9980
DOI
10.1161/JAHA.114.001611
language
English
LU publication?
yes
id
1e476851-d59f-40d5-b8e2-1110c3162ed4 (old id 5345124)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25854796?dopt=Abstract
date added to LUP
2015-05-06 14:34:40
date last changed
2017-11-12 03:50:03
@article{1e476851-d59f-40d5-b8e2-1110c3162ed4,
  abstract     = {Patients with myocardial infarction (MI) and concomitant chronic obstructive pulmonary disease (COPD) constitute a high-risk group with increased mortality. β-Blocker therapy has been shown to reduce mortality, prevent arrhythmias, and delay heart failure development after an MI in broad populations. However, the effect of β-blockers in COPD patients is less well established and they may also be less treated due to fear of adverse reactions. We investigated β-blocker prescription at discharge in patients with COPD after MI.},
  author       = {Andell, Pontus and Erlinge, David and Smith, Gustav and Sundström, Johan and Lindahl, Bertil and James, Stefan and Koul, Sasha},
  issn         = {2047-9980},
  language     = {eng},
  number       = {4},
  pages        = {001611--001611},
  publisher    = {Wiley-Blackwell},
  series       = {Journal of the American Heart Association},
  title        = {β-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study.},
  url          = {http://dx.doi.org/10.1161/JAHA.114.001611},
  volume       = {4},
  year         = {2015},
}